Difference between revisions of "MEDICATION-LIGNOCAINE"

Revision as of 12:30, 21 December 2022

1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.

2. Indications: VF/pulseless or VT refractory to defibrillation.

SE

3. Nausea & vomiting.

4. CNS: slurred speech, drowsiness, seizures.

5. CVS: bradycardia, heart block, asystole.

DOSAGE

6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.

@@ Line 1: / Line 1: @@
 [[Summary Article|<h5>'''SUMMARY ARTICLE'''</h5>]]
 <br/>
-<div>1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.<div>2. Indications: VF/pulseless or VT refractory to defibrillation.</div><div><br></div><div>SE</div><div>3. Nausea & vomiting.</div><div>4. CNS: slurred speech, drowsiness, seizures.</div><div>5. CVS: bradycardia, heart block, asystole. </div><div><br></div><div>DOSAGE</div><div>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.  </div>
+<div>1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.<div>2. Indications: VF/pulseless or VT refractory to defibrillation.</div><div><br/></div><div>SE</div><div>3. Nausea &amp; vomiting.</div><div>4. CNS: slurred speech, drowsiness, seizures.</div><div>5. CVS: bradycardia, heart block, asystole. </div><div><br/></div><div>DOSAGE</div><div>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.  </div>
-==Reference(s)==
-Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
-<br/>American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.
 [[Category:Medication]]
 [[Category:Advanced Life Support]]